Other Interesting Articles

Synthetic Data: A guide for SMEs

BREATHE — The Health Data Research Hub for Respiratory Health and PIONEER — The Health Data Research Hub for Acute Care, with funding from In...
Read Article

EAVE II was announced as the winner of HDR UK’s Impact of the Year award for its research into the effectiveness of first dose COVID-19 vaccinations. This highlights the incredible efforts made by the entire team over the past year, and how their research is making significant impact in the pandemic.

The award was received for the study “Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland”.

This in-depth study was the first of its kind to describe the effect of the first dose vaccinations across an entire country (Scotland). The team found that the vaccines were effective at reducing hospitalisations resulting from COVID-19, with an 83% reduction across both vaccines after four weeks in those aged 80 and over. 

National and international impact of the study

This study generated crucial evidence that confirmed vaccine effectiveness in all age groups and has influenced global vaccine rollout. The UK Prime Minister and Scotland’s First Minister both announced the findings in press conferences that influenced the relaxing of UK lockdown.

Following publication of these findings, several countries – France, Canada, and Germany – altered their policy positions, making the Oxford-AstraZeneca vaccine available to older people.

The story was one of the leading media stories in the world, on the day of release, and boosted public confidence in the effectiveness of COVID-19 vaccines.

“Working with data on a national scale – in strong partnership between academia and Public Health Scotland – the EAVE II team has been able to move at speed in a secure environment to answer key questions about COVID-19 vaccinations in the real world.
Thank you to all involved in both EAVE II and the UK-wide DaC-VaP studies, as we continue to provide evidence to help inform government and public health responses to this pandemic in Scotland, the UK, and internationally.”

Professor Aziz Sheikh,
Director of the Usher Institute and EAVE II and DaC-VaP Study Lead

Read more

HDR UK news announcing annual award winners 2021

Visit the EAVE II website

Back to News